Clinical inertia: Overcoming a major barrier to diabetes management

Insulin

Volumn 1, Issue 2, 2006, Pages 61-64

  Shaefer Jr , Charles F ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

clinical inertia; diabetes; glycemic control; glycosylated hemoglobin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ACCURACY; ARTICLE; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INTERNET; MEDICAL PRACTICE; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; SYMPTOMATOLOGY;

EID: 33745676141     PISSN: 15570843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1557-0843(06)80011-4     Document Type: Article

References (21)

1. Phillips L.S., Branch W.T., Cook C.B., et al. Clinical inertia. Ann Intern Med 135 (2001) 825-834
2. el-Kebbi I.M., Ziemer D.C., Musey V.C., et al. Diabetes in urban African-Americans. IX. Provider adherence to management protocols. Diabetes Care 20 (1997) 698-703
3. Available at:. Centers for Disease Control and Prevention. Data & Trends. Accessed (January 30, 2006). http://www.cdc.gov/diabetes/statistics/incidence/figl.htm
4. Koro C.E., Bowlin S.J., Bourgeois N., and Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: A preliminary report. Diabetes Care 27 (2004) 17-20
5. [published correction appears in Lancet. 1999;354:602]. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
6. Bungard T.J., Ghali W.A., Teo K.K., et al. Why do patients with atrial fibrillation not receive warfarin?. Arch Intern Med 160 (2000) 41-46
7. Kravitz R.L., Hays R.D., Sherbourne C.D., et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 153 (1993) 1869-1878
8. Bernard A.M., Anderson L., Cook C.B., and Phillips L.S. What do internal medicine residents need to enhance their diabetes care?. Diabetes Care 22 (1999) 661-666
9. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90 (1991) 450-459
10. Stout R.W. Insulin and atheroma. 20-Yr perspective. Diabetes Care 13 (1990) 631-654
11. Khaw K.T., Wareham N., Bingham S., et al. Association of hemoglobin Al c with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk. Ann Intern Med 141 (2004) 413-420
12. Brown J.B., and Nichols G.A. Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Manag Care 9 (2003) 213-217
13. Wallace T.M., and Matthews D.R. Poor glycaemic control in type 2 diabetes: A conspiracy of disease, suboptimal therapy and attitude. QJM 93 (2000) 369-374
14. Wetzler H.P., and Snyder J.W. Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes. Diabetes Care 23 (2000) 1637-1641
15. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 Suppl 1 (2006) 54-542
16. American Association of Clinical Endocrinologists. Medical guidelines for the management of diabetes mellitus: The AACE system of intensive diabetes self-management-2002 update. Endocr Proct 8 Suppl 1 (2002) 40-82
17. Riddle M.C., Rosenstock J., Gerich J., and Insulin Glargine 4002 Study Investigators. The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26 (2003) 3080-3086
18. Hirsch I.B., Bergenstal R.M., Parkin C.G., et al. A real-world approach to insulin therapy in primary care practice. Clin Diabetes 23 (2005) 78-86
19. [published correction appears in Am J Cordial. 1999;84:1143]. Sueta C.A., Chowdhury M., Boccuzzi S.J., et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cordial 83 (1999) 1303-1307
20. Ziemer D.C., Doyle J.P., Barnes C.S., et al. An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Ameri cans with Diabetes (IPCAAD) 8. Arch Intern Med 166 (2006) 507-513
21. Kennedy L., Herman W.H., Strange P., Harris A., and GOAL A1C Team. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbAl C on glycemic control in patients with type 2 diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 29 (2006) 1-8